EHMT2 and Peritoneal Fibrosis: In a separate study, the same group found that pharmacological inhibition of G9a attenuated peritoneal fibrosis and improved peritoneal function in a murine model of peritoneal fibrosis induced by methylglyoxal (Maeda et al., 2017).